# Sunshine Biopharma Inc.: Form 8-K, filed Apr 28, 2022

- Company: [Sunshine Biopharma Inc.](/companies/sbfm.md) (CIK 1402328)
- Form: 8-K
- Filed: 2022-04-28
- Accepted by EDGAR: Apr 28, 2022, 17:03 ET
- Period: 2022-04-25
- Accession: 0001683168-22-003015
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1402328/000168316822003015/sunshine_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1402328/000168316822003015/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1402328/000168316822003015/sunshine_8k.htm

Filed Apr 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001683168-22-003015. Last ingested by Listed: Nov 11, 2026, 03:50 ET. No prices; not investment advice.